Additional file 4. AUC and sensitivity for all 92 proteins comparing early stage ovarian cancer versus healthy. Comparison of ProseekŽ Oncology I values for serum samples from early stage high grade serous ovarian cancer patients versus healthy women. ROC curves for the 12 proteins with the highest AUC values are shown in Fig. 6
Ovarian cancer is the most lethal gynaecological malignancy in North America. Although survival rate...
Background: CA125 is the best available yet insufficiently sensitive biomarker for early detection o...
Ovarian cancer is usually detected at a late stage and the overall 5-year survival is only 30-40%. A...
Additional file 1. List of all 92 proteins with their significance in trends among patient subgroups...
Ovarian cancer is the fifth leading cause of cancer death in women in the U.S. Currently, two serum ...
Abstract Background Currently, there are no FDA approved screening tools for detecting early stage o...
Additional file 2: Table S2 Average Chi Square value per gene symbol for ovarian cancer versus norma...
Additional file 1: Table 1. P-values of individual proteins in the discovery step
Additional file 2: Table 2. CA125 values in the clinical analyses and the PEA NPX values for some o...
Copyright © 2015 Oleg Blyuss et al. This is an open access article distributed under the Creative Co...
Objective Survival in epithelial ovarian cancer (EOC) remains poor. Most patients are diagnosed in l...
CA125 is the best available yet insufficiently sensitive biomarker for early detection of ovarian ca...
FDA-cleared ovarian cancer biomarkers are limited to CA-125 and HE4 for monitoring and recurrence an...
Additional file 2: Figure S1âS3. Comparisons of the fluctuation patterns of blood glucose, serum i...
ObjectiveSurvival in epithelial ovarian cancer (EOC) remains poor. Most patients are diagnosed in la...
Ovarian cancer is the most lethal gynaecological malignancy in North America. Although survival rate...
Background: CA125 is the best available yet insufficiently sensitive biomarker for early detection o...
Ovarian cancer is usually detected at a late stage and the overall 5-year survival is only 30-40%. A...
Additional file 1. List of all 92 proteins with their significance in trends among patient subgroups...
Ovarian cancer is the fifth leading cause of cancer death in women in the U.S. Currently, two serum ...
Abstract Background Currently, there are no FDA approved screening tools for detecting early stage o...
Additional file 2: Table S2 Average Chi Square value per gene symbol for ovarian cancer versus norma...
Additional file 1: Table 1. P-values of individual proteins in the discovery step
Additional file 2: Table 2. CA125 values in the clinical analyses and the PEA NPX values for some o...
Copyright © 2015 Oleg Blyuss et al. This is an open access article distributed under the Creative Co...
Objective Survival in epithelial ovarian cancer (EOC) remains poor. Most patients are diagnosed in l...
CA125 is the best available yet insufficiently sensitive biomarker for early detection of ovarian ca...
FDA-cleared ovarian cancer biomarkers are limited to CA-125 and HE4 for monitoring and recurrence an...
Additional file 2: Figure S1âS3. Comparisons of the fluctuation patterns of blood glucose, serum i...
ObjectiveSurvival in epithelial ovarian cancer (EOC) remains poor. Most patients are diagnosed in la...
Ovarian cancer is the most lethal gynaecological malignancy in North America. Although survival rate...
Background: CA125 is the best available yet insufficiently sensitive biomarker for early detection o...
Ovarian cancer is usually detected at a late stage and the overall 5-year survival is only 30-40%. A...